Found: 4
Select item for more details and to access through your institution.
Overview of Neutralizing Antibodies and Their Potential in COVID-19.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1376, doi. 10.3390/vaccines9121376
- By:
- Publication type:
- Article
Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2.
- Published in:
- Vaccines, 2021, v. 9, n. 9, p. 1047, doi. 10.3390/vaccines9091047
- By:
- Publication type:
- Article
Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 742, doi. 10.3390/vaccines9070742
- By:
- Publication type:
- Article
Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study.
- Published in:
- Journal of Inflammation Research, 2022, v. 15, p. 4449, doi. 10.2147/JIR.S374304
- By:
- Publication type:
- Article